What stage does Peregrine Ventures invest at?

Peregrine Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is Peregrine Ventures's typical check size?

Peregrine Ventures typically writes checks of $500K – $3M.

What sectors does Peregrine Ventures focus on?

Peregrine Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Peregrine Ventures located?

Peregrine Ventures is headquartered in Or Yehuda, IL.

Peregrine Ventures

Venture capital

Or Yehuda · Seed–Late Stage · 14 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Peregrine Ventures, described as Israel's first dedicated healthcare fund, invests in and supports life science and medical technology companies with the goal of improving patient quality of life. It combines deep industry knowledge with an embedded, synergetic strategy, helping portfolio companies with business, regulatory, and investment strategies. The firm backs companies from seed and early/mid-stage through advanced growth, supporting them in building business strategies, forming strategic alliances, recruiting teams, and bringing healthcare innovations to market. Its dedicated investment vehicles include early and mid-stage funds, the 'Incentive' Incubator, and Peregrine Growth, a fund for mature companies in their final financing rounds before an M&A or IPO.

Invests inBiotech Digital Health Healthtech Medical DevicesGlobalIsrael

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Check

$500K – $3M

Or Yehuda, IL

Instruments

Equity

Founded

2001

AUM

$205M

Tracked investments

Team · 14 people

from the firm's website & public directories

Eyal Lifschitz· Cofounder & Managing General Partner· Israelin

Entrepreneur who founded and managed several medical technology companies including PharmaSys, ECR, Visioncare and BioControl, and served as a director of Given Imaging. Chairs the Israeli Early-Stage Investors Association and holds an LLB.

Boaz Lifschitz· General Partner· Tel Aviv, Israel

Cofounded biomedical device companies Visioncare and BioControl and was an active investor before founding Peregrine. Has served on numerous portfolio company boards. Holds a BSc from Bar-Ilan and an MSc from Boston/Ben-Gurion universities.

b•••@peregrinevc.comreveal

Eyal Lifshitz· Managing General Partner

e•••@peregrinevc.comreveal

Lior Shahory· General Partner· Israelin

With Peregrine since 2005 and CEO of its Incentive tech incubator, contributing experience in investments, due diligence and business development. Previously deputy director of Israel's Chief Scientist incubator program. Holds a BA and an MBA.

l•••@peregrinevc.comreveal

Ruben Schächter· Investment Director & Head of Europe· Israelin

A member of Peregrine since 2021 responsible for growth via M&A and investments and oversight of the European market. Previously ran investment banking at a European bank and co-founded investment consortium ACK. Holds a law degree from the University of Zurich.

r•••@peregrinevc.comreveal

Tal Carasso· Venture Partner, Director of Investor Relations, Business Development· Israelin

Joined Peregrine in 2011 and manages investor relations and business development during fundraising, plus screening of potential portfolio companies. Holds an MA in organizational consulting and a BA in communications and management.

Tamir Tal· Venture Partner· Or Yehuda, Israel

With Peregrine since 2005, involved in M&A, investments and growth finance, and CEO of portfolio company Cordio Medical. Former corporate lawyer and COO at Neovasc Medical and Geomage. Holds an LLB and MBA from Tel Aviv University.

David Eldar· Venture Partner· Or Yehuda, Israel

Joined Peregrine in 2008; previously CFO of ObserveIT and Proficiency and VP Finance at ID Gene. A Certified Public Accountant since 1996 with a business degree from Tel Aviv's College of Management.

d•••@peregrinevc.comreveal

Amit Alfasi· Marketing Communications and Investor Relationsin

Joined Peregrine in 2019 overseeing media communications, PR, investor relations and brand strategy. Holds a BSc in nutrition science and an MBA in marketing.

Elazer R. Edelman· Chairman of the Medical Advisory Board· Brookline, Massachusetts, United Statesin

Professor in medical engineering at MIT and medicine at Harvard, and a senior cardiologist at Brigham and Women's Hospital. Directs MIT's IMES and holds numerous fellowships and awards.

Liat Gabay· Office Manager

Leads office operations and administrative activities, supporting partners with scheduling and investor visits. Previously held similar roles at Vertex Ventures and JVP. Holds a BA in education and is certified in bookkeeping.

Tamar Ben-Zvi· Diagnostics, Business Development

Joined Peregrine in 2023, managing deal flow and due diligence for Peregrine and its Incentive incubator with a focus on diagnostics. Former clinical research associate at Alpha Tau Medical. Holds an MSc in biomedical sciences from the Hebrew University.

Vered Zarger· Senior Accounting Manager

Senior Accounting Manager at Peregrine with over two decades of bookkeeping and payroll experience, previously head of accounting at a production company.

Shiran Tehila Mashiah· Vice President· Israelin

Principal at Peregrine and VP of Business Development for the Incentive Incubator specializing in pharma and biotech investments since 2020. Serves on several portfolio company boards. Holds an MSc in molecular biology from the Weizmann Institute and an MBA.

s•••@peregrinevc.comreveal

What they invest in

from 8 of 65 portfolio companies

Healthtech ×7Digital Health ×4Biotech ×3Medical Devices ×2AI & Machine Learning ×1B2B Marketplaces ×1Logistics & Supply Chain ×1

HQs:United States×3Israel×1Nigeria×1

Investments · 65 tracked

founders shown can be your intro path

By year:2025 · 1 2021 · 23 dated

Cordiocordio-med.cominSep 2021✓ verified

Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Chaim Lotan(Executive Officer, Director)Ronit Haviv(Executive Officer)David Lifschitz(Director)Lior Shahori(Director)Ilan Shalom(Executive Officer)Leon Eting(Executive Officer)

Incentiveincentive-il.com✓ verified

Incentive is Israel's first privatized incubator focused on medical and healthcare innovation, investing in and supporting portfolio companies developing healthcare technologies.

Digital HealthHealthtechMedical DevicesOr Yehuda, IL

Variantyxvariantyx.cominFeb 2021✓ verified

Variantyx provides genetic testing services used to help diagnose rare conditions, guide cancer treatment, and inform pregnancy decisions for patients and their families.

BiotechDigital HealthHealthtechFramingham, US

Zafrira Avnur(Became a director following financing closing.)Noam Shomron(Was a director at financing closing.)Greg Faust(Director)Haim Neerman(Co-founder)Tomer Jackman(Co-founder & VP Customer Support and Lab Services)Jeffrey Weisberg(Chief Financial Officer)

Momentis SurgicalJul 2025

HealthtechOr Yehuda

Morry Blumenfeld(Director)Nataly Fellous(Vice President Finance)Maurice Ferre(Chairman)Michael Stansky(Director)Sandra Morgan(Director)Frederic Moll, M.D.(Director)

Board seatLior ShahoryEyal Lifschitz· per SEC Form D

Aleph Farmsaleph-farms.comin 𝕏

Althea Medical

Aluma

AnserBio

ArTack Medical

ArtFix

B-Balloon

Bio Protectbioprotect.comin 𝕏

Bio Refine

Bluewhite

BrainQ

Breakthrough therapies for neurorecovery

Cardio Gard

CardioMEMScookiedatabase.org

Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.

BiotechHealthtechAlbuquerque, US

Thomas Duensing(Executive Officer)Dennis Hynson(Executive Officer)Jack T. Ball(Director)J. Michael Schafer(Director)Janette Phi(Executive Officer)Bo E.H. Saxberg(Director)

Cardiovalve

CartiHeal

ClearMargin

ConAir Medical

Curesign

DairyX

Digma

Eledon

Endomatic

EndoPulse

Endostream

EviCure

Eximo

Focal Medical Technology

Hairstetics

HeraCure

Insightecinsightec.comin 𝕏

HealthtechTirat Carmel

Brett Chugg(Director)Sim Mann(Director)Ron Hadassi(Director)Jeremy Blank(Director)Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)

IonaraBio

Kahr

Kanso

Levation Pharma

Life Therapeutics

Lutris Pharmalutris-pharma.com

Magneto

Magnisity

Mpharmampharma.com

mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.

B2B MarketplacesDigital HealthHealthtechLogistics & Supply Chain

NectinTx

Neovasc

NextVivo

NitiNotes

NLT

OncoRedox

Outsense

Potentia Therapeutics

Raziel

Restore Medical

Ribon Therapeutics

BiotechLexington, US

Cameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)Victoria M. Richon(Executive Officer, Director)

SinuSafe

Snipe

SuperSpectra

Terrapeutics

Trojan Bio

Validify

Portfolio news

latest coverage across their companies

Gregory Rockson’s mPharma gets funding to accelerate healthcare access

Mpharma · billionaires.africa · Dec 22, 2025

Frequently asked questions

What stage does Peregrine Ventures invest at?: Peregrine Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Peregrine Ventures's typical check size?: Peregrine Ventures typically writes checks of $500K – $3M.
What sectors does Peregrine Ventures focus on?: Peregrine Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Peregrine Ventures located?: Peregrine Ventures is headquartered in Or Yehuda, IL.

Images

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

Capricorn Venture Partners

Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.

$270K – $10.8M

Novartis Venture Fund

The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.

$5M – $25M

EQT Life Sciences

EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.

$11M – $66M

Portfolia

Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.